We have compared the efficacy of local UVB photother apy with topical (bath) photochemotherapy in 13 patients with bilateral chronic hand dermatitis. In each patient, one hand was treated with UVB phototherapy and the other hand with topical (bath) photochemotherapy. Both treatments moderately improved the chronic hand der matitis after 6 weeks' treatment. We observed no signifi cant differences in improvement between the modalities, but side-effects occurred more often on the photochemotherapy-treated side. Considering the similar responses and relative incidence of side-effects, we would advise starting treatment with UVB phototherapy and only using topical photochemotherapy if this fails.
PUVA.11 Topical PUVA also carries this risk but it is not known whether this differs from that of oral PUVA; it has, however, been suggested that topical treatment may be safer.1 '13 Nevertheless, in view of the probable greater safety of UVB phototherapy, we have carried out a leftright comparison of its therapeutic efficacy as compared with that of topical bath PUVA in chronic hand dermatitis.
Patients
Thirteen patients with bilateral chronic hand dermatitis entered the study after informed consent was obtained, the disorder being defined as an eruption with vesicles or hyperkeratotic plaques of the hands present for longer than 6 months. Patients with severe vesiculation or bullae or with evidence of psoriasis were excluded. Photo dermatoses, light-aggravated dermatoses, and a history of melanoma, immunosuppressive therapy, severe impair ment of renal or liver function or pregnancy were reasons for exclusion.
In all patients, cutaneous patch testing was first under taken with the European standard series following Inter national Contact Dermatitis Research Group (ICDRG) guidelines; intracutaneous skin tests were also performed with a standard tray (Bencard, Artu Biologicals, Lelystad, The Netherlands).
Methods
Each patient was treated with local UVB phototherapy on one hand and topical (bath) PUVA on the other, alternate patients being selected for UVB phototherapy for the right hand and topical PUVA for the left and vice versa. UVB phototherapy was carried out three times a week and topical PUVA treatment twice. All patients were treated for 6 weeks with the exception of one patient who cleared after 3 weeks. At the end of the 6 weeks, we continued the therapy with both modalities if a compar able clinically significant improvement was obtained, 2 26-50% , area we phototherapy or topical PUVA if a clinically greater scored the intensity of erythema and oedema, vesicles improvement had occurred with one of the modalities, and papules, and dryness, scaling and hyperkeratosis, on From 1 week before the start until the end of the study a 0-3 scale none, 1 irate, the participants were not allowed to use any medication 3 severe). Finally, for each area we multiplied together other than bland emollients for the hands, and all were the percentage of the affected area, the correction factor instructed to avoid contact with water and irritants and to and the sum of the intensities of the symptoms, after which the total score was the sum of the scores o f the avoid relevant allergens where possible.
Clinical evaluation seven areas. We also independently evaluated the sub jective complaints o f itching and pain on a 0 -3 scale.
Before the start o f the study we assessed the minimal At the start of treatment and at 2-weekly intervals, the erythema dose (M ED) and the minimal phototoxic dose hands were evaluated by means o f a clinical assessment (MPD) on the ventral side of the forearm in 10 healthy score, based on a severity index corrected for the size of volunteers; the mean M E D was 54 s (0*18J /cm 2) and the affected skin area. For this, we divided each hand into 80 s (0162 J /cm "), respectively. We then started treatment seven areas, the palm, the back of the hand and the five with 40% o f the mean M ED or MPD. The incremental fingers, each area having its own correction factor based dose at each treatment was 20% for topical PUVA, while on the relative size o f this skin area, estimated for the for UVB we started with 20% increments for the first five palm and back o f the hand as 0-25 and for the fingers 01; treatments and then slowly tapered the incremental the percentage of the area affected was then indicated on if slight erythema occurred, however, the dose was not 
T O P IC A L P H O T O T H E R A P Y O F H A N D D E R M A T IT IS 9
F8T5 PUVA tubes) above a Waldmannn PUVA 180 unit the UVB-treated side and 10*17 on the PUVA side, while (five F15T8 PUVA and three TL-09 Philips afterwards it was 5-51 on the UVB side and 7-66 on the tubes), the emission spectrum being 3 1 5 -4 0 0 nm and PUVA side; this corresponds to a 39 in intensity 7-2-8-2m W /cm i'. score for the UVB side (P < 0*05) and 25% for the With both methods, the hands were put into the light PUVA side (P < 0*05). This difference in unit with the palmar surface downwards resting on the was not statistically significant (P > 0-05). glass plate of the 200 unit.
Individually, the reductions in score var from to ) for UVB and from -2 6 % to 100% )
S ta tisi ica I m et h o ds
Both PUVA and of one-ts compare efficacies were evaluated by means 's /-test for paired samples to e treatment and at 6
for PUVA, the minus sign denoting deterioration (see Table 2 ) while the mean number of treatments for UVB was 17 and for PUVA 11, the mean total dose of UVB being 5-7 J /c m 2 and of UVA 7-1 J /cm 2.
weeks. To compare the relative UVB and PUVA treatment two-tailed t-test • pairea samples. All 13 patients suffered from different degrees of itching on both hands; after 6 weeks, however, six were free o f the discomfort on both sides and three remarkably better
Vr
There were seven male and six female patients with hand on the UVB side, while in four there was no change. We dermatitis of the palms and the fingers with mean age 47 noted no marked change in pain, however, nine patients years 5 months. The mean duration o f the dermatitis was initially complaining of this in both hands and eight still 5 years 8 months; in all patients it was o f the chronic type complaining of it after 6 weeks. not f to topical treatment or avoidance o f At the end of the 6 weeks, treatment was continued in allergic or irritant contact factors. In 12 patients, vesicles nine o f the patients. Three received PUVA to both hands, were observed during the course o f the disease. Five with improvement but not total clearance in two, though patients showed positive cutaneous patch tests, there this was slow on the side previously treated with UVB, being positive reactions to chromate and cobalt in one while in two others UVB was continued to both hands for and just chromate in another; a further one showed 6 and 11 further weeks, respectively; slight to moderate positive reactions to monothioglycollate and thioglycollic improvement was achieved on the side initially treated one to primin, and one PUVA, while in one patient the hand that had multiple positive reactions to thiuram, formaldehyde, received UVB from the beginning became almost totally quarternium 15, iodine tincture, benzoyl peroxide and diazolidinylurea. Nine of atopic bv 12 Thi *ee patients were a ¡ease and 10 showed one or more PUVA on one side and UVB on the other for 8 -1 4 weeks; two showed improvement in both intracutaneous skin tests. At the time o f inclusion in the more on the PUVA side, while in the study, however, none of these positive tests were appar-were almost clear after 12 weeks, ently relevant to the eczema, although in nine patients, irritant factors probably played a significant part. Three
Si de-effects
During the 6-week observation period, two patients UV radiation-induced erythema of the patients were of skin type II, seven skin type III and three skin type IV as defined by Fitzpatrick.1'* Twelve patients were treated with UVB and PUVA for at least 6 weeks. One cleared completely after 3 weeks of UVB-treated side on a total of three occasions, while and was still clear after 6 weeks; in this six suffered phototoxic reactions from PU VA on a total of case, we used the clinical score at 3 weeks as the score for nine occasions; skin type did not seem relevant to the s. In ; 6 weeks. Pour patients discontinued therapy because o f a development of lack of significant improvement after 6 weeks, and we treated side became for more pigmented than the UVB. chose to continue PUVA for both hands in three other cases and U VB in two; in three, however, there was no significant difference between the therapies and in these we continued UVB for one hand and PUVA for the other. We cannot conclude that or PUVA treatment of chronic hand dermatitis has higher
Comparison o f the U VB and P U V 4 treatment ejficacies
The results after 6 efficacy than the other, the higher mean percentage o f in the total severity scores after local ♦* treatment are listed in (39%) compared with topical bath PUVA (25%) after 6 Table 1 , the mean total score before being 8*98 on weeks of treatment not being statistically significant. 
